| mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
-0.0091 |
0.9 |
| mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
| mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.9 |